SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-056256
Filing Date
2024-05-09
Accepted
2024-05-09 07:06:23
Documents
13
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qttb-20240509.htm   iXBRL 8-K 39543
2 EX-99.1 qttb-ex99_1.htm EX-99.1 129398
3 GRAPHIC img38152436_0.jpg GRAPHIC 3407
  Complete submission text file 0000950170-24-056256.txt   298471

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20240509.xsd EX-101.SCH 25022
16 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20240509_htm.xml XML 4727
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 24928510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)